Skip to main navigation Skip to search Skip to main content

Long-Term Effect of Macrolides on Helicobacter pylori Eradication: Data From the European Registry on Helicobacter pylori Management (Hp-EuReg)

  • the Hp-EuReg investigators
  • Hospital Universitario de la Princesa
  • Lithuanian University of Health Sciences
  • Hospital Costa Del Sol
  • DC Rogaska
  • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
  • Hospital de Cabuenes
  • Hospital General Universitario de Valencia
  • Clinica Quiron
  • Francisco de Vitoria University
  • Hospital Universitario de Valme
  • University of Porto
  • Hospital Universitario Río Hortega
  • Hospital Universitario Virgen del Rocio
  • Tallaght Hospital
  • Hospital Universitario 12 de Octubre
  • Hospital Universitario Virgen Macarena
  • Hospital Universitario San Jorge
  • Interni Oddelek
  • University of Bologna
  • Semmelweis University
  • Østfold Hospital Trust
  • University of Bari
  • Hospital Sierrallana
  • NHS Grampian
  • Hospital Clinico Universitario Zaragoza
  • Trinity College Dublin
  • Fondazione Policlinico Universitario “A. Gemelli” IRCCS
  • Hospital Universitario Santa Bárbara
  • Infanta Sofía University Hospital
  • Hospital de Cruces
  • Hospital Universitario de Burgos
  • Hospital Universitario Marques de Valdecilla
  • Centro de Salud María Auxiliadora (SERMAS)
  • Instituto de Investigación Sanitaria Biodonostia
  • Fundació Althaia - Xarxa Assistencial Universitària de Manresa
  • University of Barcelona
  • Université de Bordeaux
  • University of the Basque Country

Research output: Contribution to journal › Article › peer-review

Abstract

Background and Aims: Previous antibiotic use influences Helicobacter pylori antibiotic resistance. This study evaluated how prior population-level macrolide (especially clarithromycin) use affects H. pylori eradication success in naïve patients. Methods: Retrospective, multicenter, ecological study. Multivariate logistic regression was performed with modified intention-to-treat effectiveness as the main outcome. Key variables included first-line clarithromycin-based treatments, therapy duration (7, 10, 14 days), proton pump inhibitor dose (low, standard, high), compliance (> 90%), and clarithromycin consumption (defined daily doses/1000 inhabitants/day, from the European Surveillance of Antimicrobial Consumption Network). Nested hierarchical models incorporated macrolide consumption, matched by year and country, and assessed the interaction between consumption and first-line empirical treatments from the European Registry on H. pylori Management (Hp-EuReg). Results: The study included 27,549 naïve patients from 23 countries with macrolide consumption data from 2013 to 2022. Higher macrolide consumption, within 0 to 8 years before treatment, was associated with reduced treatment effectiveness. The eradication rate consistently decreased as macrolide consumption increased, particularly within the previous 4 years. The efficacy of triple-clarithromycin-metronidazole, triple-clarithromycin-amoxicillin, and some bismuth-quadruple therapies containing clarithromycin decreased with higher macrolide consumption. At the country level, higher population consumption of clarithromycin 2 years before treatment was associated with a decrease in eradication rates from 93% to 82%. Conclusion: Higher macrolide consumption in the general population negatively impacts the effectiveness of first-line H. pylori regimens. These findings support that clarithromycin should only be administered as a susceptibility-based therapy, with the strongest negative impact of prior population-level exposure observed within 5 years and diminishing thereafter. ClincialTrials.gov number, NCT02328131.

Original languageEnglish
Article numbere70107
Number of pages12
JournalHelicobacter
Volume31
Issue number1
DOIs
Publication statusPublished - 1 Jan 2026

OECD Field of Science

  • 3.2 Clinical Medicine

Keywords

  • antibiotic consumption
  • clarithromycin
  • eradication treatment
  • H. pylori
  • macrolide
  • resistance

Fingerprint

Dive into the research topics of 'Long-Term Effect of Macrolides on Helicobacter pylori Eradication: Data From the European Registry on Helicobacter pylori Management (Hp-EuReg)'. Together they form a unique fingerprint.

Cite this